Endo USA, Inc.401(k)
ENDO PHARMACEUTICALS SAVINGS AND INVESTMENT PLAN · MALVERN, PA · plan year 2023
Peer grade: B+ · admin costs + employer contributions vs same-size plans · how grading works
Endo USA, Inc. reported $316,206 in plan administrative expenses for 2023: 0.07% of average plan assets, below the peer median. Employer contributions averaged $4,783 per active participant. This ratio covers administrative expenses reported on the plan's Schedule H only; fund-level expense ratios are not included in public structured data — see methodology.
Across the 1 year on file its reported administrative ratio rose from 0.06% to 0.07%. The plan sits in the $250M–$1B size bracket, benchmarked here against 2,601 comparable plans and shown alongside other manufacturing employers. By assets it is the 152nd-largest of 3,651 plans among Pennsylvania employers on file, and the 575th of 13,661 in manufacturing. In 2023, employees put in $2.71 for every $1.00 the employer contributed.
Endo USA, Inc.'s 2023 employer contribution ran above the $4,362 median for plans its size. Filings report dollars actually contributed, not the match formula; the formula itself (for example, 50% of the first 6% of pay) lives in the plan's summary plan description from HR.
Annual cost at the plan's reported 2023 administrative ratio, against the median plan its size; fund expense ratios are extra. Compare any plan.
Compensation shown is direct payments from plan assets reported on Schedule C. Providers paid through fund revenue-sharing appear as indirect.
Why are you looking at this plan?
Source: U.S. Department of Labor, Form 5500 series, EIN 522035829 · Verify on EFAST2 · Amounts are as reported by the plan sponsor for the plan year shown.